Julian Jenkins, vice president of project planning and management at GlaxoSmithKline, is the head of the company’s digital platform performance unit. GSK is consolidating all of its efforts in the digital clinical space into one group so it can coordinate across the business, run it in a more effective way and then hopefully adopt new digital methodology in its clinical trials.
Saturday, 12 March 2016
The Value Proposition for mHealth in Clinical Trials
Julian Jenkins, vice president of project planning and management at GlaxoSmithKline, is the head of the company’s digital platform performance unit. GSK is consolidating all of its efforts in the digital clinical space into one group so it can coordinate across the business, run it in a more effective way and then hopefully adopt new digital methodology in its clinical trials.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment